Non-Vitamin K Antagonist Oral Anticoagulants : A Concise Guide.

Yazar:Shantsila, Eduard
Katkıda bulunan(lar):LIP, Gregory
Materyal türü: KonuKonuYayıncı: Cham : Springer International Publishing AG, 2015Telif hakkı tarihi: �2016Tanım: 1 online resource (82 pages)İçerik türü:text Ortam türü:computer Taşıyıcı türü: online resourceISBN: 9783319254609Tür/Form:Electronic books.Ek fiziksel biçimler:Print version:: Non-Vitamin K Antagonist Oral AnticoagulantsLOC classification: R1Çevrimiçi kaynaklar: Click to View
İçindekiler:
Intro -- Contents -- Chapter 1: Introduction -- 1.1 Overview of the Coagulation Cascade -- 1.2 Current Approaches to Anticoagulation -- 1.3 The Ideal Anticoagulant -- References -- Chapter 2: Direct Thrombin Inhibitors -- 2.1 Historical Excursus: Ximelagatran -- 2.2 Dabigatran Etexilate -- 2.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 2.2.2 Venous Thromboembolism Treatment -- 2.2.3 Stroke Prevention in Atrial Fibrillation -- 2.2.4 Other Directions -- References -- Chapter 3: Factor Xa Inhibitors -- 3.1 Rivaroxaban -- 3.1.1 Venous Thromboembolism Prevention following Joint Surgery -- 3.1.2 Treatment of Venous Thromboembolism -- 3.1.3 Stroke Prevention in Atrial Fibrillation -- 3.1.4 Acute Coronary Syndromes -- 3.2 Apixaban -- 3.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.2.2 Stroke Prevention in Atrial Fibrillation -- 3.2.3 Thromboprophylaxis in Other Clinical Settings -- 3.2.4 Treatment of Venous Thrombosis -- 3.2.5 Acute Coronary Syndrome -- 3.3 Edoxaban -- 3.3.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.3.2 Stroke Prevention in Atrial Fibrillation -- 3.3.3 Treatment of Venous Thromboembolism -- 3.4 Emerging Factor Xa Inhibitors -- 3.4.1 Betrixaban -- 3.4.2 TTP889 -- References -- Chapter 4: Conclusions -- 4.1 Future Directions -- References.
Bu kütüphanenin etiketleri: Kütüphanedeki eser adı için etiket yok. Etiket eklemek için oturumu açın.
    Ortalama derecelendirme: 0.0 (0 oy)
Bu kayda ilişkin materyal yok

Intro -- Contents -- Chapter 1: Introduction -- 1.1 Overview of the Coagulation Cascade -- 1.2 Current Approaches to Anticoagulation -- 1.3 The Ideal Anticoagulant -- References -- Chapter 2: Direct Thrombin Inhibitors -- 2.1 Historical Excursus: Ximelagatran -- 2.2 Dabigatran Etexilate -- 2.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 2.2.2 Venous Thromboembolism Treatment -- 2.2.3 Stroke Prevention in Atrial Fibrillation -- 2.2.4 Other Directions -- References -- Chapter 3: Factor Xa Inhibitors -- 3.1 Rivaroxaban -- 3.1.1 Venous Thromboembolism Prevention following Joint Surgery -- 3.1.2 Treatment of Venous Thromboembolism -- 3.1.3 Stroke Prevention in Atrial Fibrillation -- 3.1.4 Acute Coronary Syndromes -- 3.2 Apixaban -- 3.2.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.2.2 Stroke Prevention in Atrial Fibrillation -- 3.2.3 Thromboprophylaxis in Other Clinical Settings -- 3.2.4 Treatment of Venous Thrombosis -- 3.2.5 Acute Coronary Syndrome -- 3.3 Edoxaban -- 3.3.1 Venous Thromboembolism Prevention in Major Orthopedic Surgery -- 3.3.2 Stroke Prevention in Atrial Fibrillation -- 3.3.3 Treatment of Venous Thromboembolism -- 3.4 Emerging Factor Xa Inhibitors -- 3.4.1 Betrixaban -- 3.4.2 TTP889 -- References -- Chapter 4: Conclusions -- 4.1 Future Directions -- References.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2022. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

yorum yazmak için.

Ziyaretçi Sayısı

Destekleyen Koha